Gene therapy research in San Francisco, California

Dr. Adil Daud, MD is an institution located at 1600 Divisadero Street, San Francisco, California, United States. This institution is a doctor specializing in oncology and melanoma, with a focus on immunotherapy research. Dr. Daud is also a history and literature buff. He is the co-director of the Melanoma Center and conducts research to better understand melanoma biology and develop new treatments. Dr. Daud has led numerous clinical trials expanding the use of gene therapy for melanoma. He has received awards such as the Young Investigator Award from the American Society of Clinical Oncology and has been recognized as a Castle Connolly Top Doctor. The institution is conducting studies on advanced melanoma and other solid tumors, as well as investigating the genes predictive of response to anti-PD-1 therapy in melanoma. Dr. Daud and his team at UCSF Health are dedicated to advancing treatments for advanced skin cancer and working towards a malaria-free world through partnerships and innovative healthcare solutions. For the best experience, it is recommended to use Chrome or Firefox when visiting the UCSF Health website.

Dr. Pamela Munster, MD is a medical oncologist and the co-director of the Center for BRCA Research located in San Francisco, California, United States. She is currently conducting research on the effect of Denosumab in preventing breast cancer in women with a BRCA1 germline mutation. The institution also focuses on studying combination therapy in cancers with mutations in DNA repair genes and evaluating the efficacy and safety of various treatments for advanced solid tumors. Additionally, Dr. Munster and her team are involved in a study of Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient tumors. The institution is dedicated to advancing cancer research and providing the best possible care for patients. Please note that for the best experience, it is recommended to use Chrome or Firefox when visiting the UCSF Health website.

Dr. Alejandro Sweet-Cordero, MD is a world-class pediatric hematologist-oncologist located at 1825 4th Street, San Francisco, California, United States. He specializes in treating children with cancer, particularly sarcomas, and advanced cancers through precision medicine. Dr. Sweet-Cordero is known for his extraordinary kid care and dedication to finding new therapies for rare conditions. With a focus on utilizing gene sequencing data to inform treatment decisions, Dr. Sweet-Cordero leads the UCSF Molecular Oncology Initiative and runs a research lab dedicated to sarcoma therapies. He earned his medical degree at UCSF and completed his fellowship at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

Dr. Catherine C. Smith, MD is a hematologist-oncologist and leukemia researcher located at 400 Parnassus Avenue in San Francisco, California. Specializing in acute leukemia and myeloproliferative neoplasms, Dr. Smith is dedicated to providing exceptional care to her patients, particularly those with acute myeloid leukemia. She is known for her expertise in treating patients with mutations in the FLT3 gene and her research focuses on developing new strategies for AML therapies. A lifelong San Francisco Giants fan, Dr. Smith earned her medical degree from Duke University and completed her fellowship at UCSF. Partnered with organizations like the Bill & Melinda Gates Foundation and Google, UCSF Health is committed to creating a malaria-free world through technology and healthcare innovations. For the best experience, we recommend using Chrome or Firefox when visiting our website.